1 / 8

Global Epidemiologic Variability of EGFR Mutation NSCLC

Global Epidemiologic Variability of EGFR Mutation NSCLC. Keunchil Park, MD, PhD Professor Division of Hematology/Oncology Department of Medicine Sungkyunkwan University School of Medicine Samsung Medical Center Seoul, Korea.

noel
Télécharger la présentation

Global Epidemiologic Variability of EGFR Mutation NSCLC

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Epidemiologic Variability of EGFR Mutation NSCLC Keunchil Park, MD, PhD Professor Division of Hematology/Oncology Department of Medicine Sungkyunkwan University School of Medicine Samsung Medical Center Seoul, Korea Epidemiologic studies can be subject to selection bias. Real-life data may differ.

  2. EGFR Epidemiologic Studies in Asia *Less than 20 pack-years or never smokers ARMS = amplification-refractory mutation system; EGFR = epidermal growth factor receptor; PNA-LNA = peptide nucleic acid-locked nucleic acid a. Yang PC, et al. ASCO 2012. Abstract 1534. b. Liam CK, et al. J Thorac Oncol. 2013;8(6):766-772. c.Choi YL, et al. PLoS One. 2013;8(2):e56011. d. Tanaka T, et al. Int J Cancer. 2010;126(3):651-655.

  3. EGFR Mutation Rates in Asia PIONEER (single study)[a] a. Yang PC, et al. ASCO 2012. Abstract 1534. b. Liam CK, et al. J Thorac Oncol. 2013;8(6):766-772. c.Choi YL, et al. PLoS One. 2013;8(2):e56011. d. Tanaka T, et al. Int J Cancer. 2010;126(3):651-655.

  4. EGFR Epidemiologic Studies in Asia *Less than 20 pack-years or never smokers a. Yang PC, et al. ASCO 2012. Abstract 1534. b. Liam CK, et al. J Thorac Oncol. 2013;8(6):766-772. c.Choi YL, et al. PLoS One. 2013;8(2):e56011. d. Tanaka T, et al. Int J Cancer. 2010;126(3):651-655.

  5. Predictors of EGFR Mutation a. Yang PC, et al. ASCO 2012. Abstract 1534. b. Liam CK, et al. J Thorac Oncol. 2013;8(6):766-772. c.Choi YL, et al. PLoS One. 2013;8(2):e56011. d. Tanaka T, et al. Int J Cancer. 2010;126(3):651-655.

  6. EGFR Mutation Rates in the West a. Rosell R, et al. N Engl J Med. 2009;361(10):958-967; b.de Mello RA, et al. Tumour Biol. 2012;33(6):2061-2068; c. Smits AJ, et al. Cell Oncol (Dordr). 2012;35(3):189-196; d. Boch C, et al. BMJ Open. 2013;3(4):e002560; e.Cote ML, et al. Thorac Oncol. 2011;6(3):627-630.

  7. Temporal Trends in EGFR Mutation Test in Korea P = .001 P < .001 Choi YL, et al. PLoS One. 2013;8(2):e56011.

  8. Thank you for participating in this activity.

More Related